$Leap Therapeutics (LPTX.US)$Leap Therapeutics Announces Completion of Enrollment in Part B of the Defiance Study of Dkn-01 for the Treatment of Colorectal Cancer Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more